Skip to main content

stock

ZOMDF · Zomedica Corp.

What Zomedica Corp. reports to the SEC, read from its filings.

Open in the app

Price

The live ZOMDF price and today's change.

Sign in to see this

Chart

Thirty days of daily bars, with signal levels drawn on them.

Sign in to see this

Signals

The latest signal group Nakagai's scanner recorded on ZOMDF.

Sign in to see this

Options positioning

Gamma exposure levels from the options market.

Sign in to see this

Technicals

Trend, momentum and volatility gauges per timeframe.

Sign in to see this

What it is

Industry
Pharmaceutical Preparations (SIC 2834)
Filer (SEC EDGAR)
EDGAR filing index
Shares outstanding
979,949,668 as of 2026-08-05 (XBRL frame CY2026Q2I)

Key stats

Valuation

P/E
Locked
P/S
Locked
P/B
Locked
Enterprise value
Locked
EV/EBIT
Locked
FCF yield
Locked

Margins

Gross
65.4%
Operating
-56.3%
Net
-51.4%

Returns

ROE
-17.7%
ROA
-16.0%

Health

Current ratio
6.4x
Debt/equity
—

Deep value

NCAV
$47.03M
NCAV per share
$0.05
Price/NCAV
Locked
NNWC
$3.61M
NNWC per share
$0.00
Price/NNWC
Locked

Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.

Sign in to see this

Debt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.

Results

Period endRevenueGross profitOperating incomeNet incomeFiling
2026-06-30$9.51M$6.04M-$4.08M-$3.77M
10-Q filed 2026-08-05
2026-03-31$8.80M$5.48M-$4.90M-$4.53M
10-Q filed 2026-08-05
Assembled from more than one filing; the filing above is only the newest of them.
2025-12-31$10.47M$7.17M-$5.16M-$4.53M
10-K filed 2026-03-16
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
2025-09-30$8.10M$5.44M-$6.61M-$6.12M
10-Q filed 2025-11-04
2025-06-30$6.96M$4.67M-$8.04M-$7.40M
10-Q filed 2026-08-05
2025-03-31$6.50M$4.41M-$64.55M-$63.81M
10-Q filed 2026-08-05
Assembled from more than one filing; the filing above is only the newest of them.
2024-12-31$7.89M$5.55M-$8.16M-$7.19M
10-K filed 2026-03-16
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
2024-09-30$7.00M$5.06M-$7.44M-$6.70M
10-Q filed 2025-11-04
Assets
$118.15M
Equity
$107.28M

Balance as of 2026-06-30.

Ten years

Fiscal year endRevenueOperating incomeNet incomeFree cash flow
2025-12-31$32.03M-$84.35M-$81.86M-$18.22M
2024-12-31$27.29M-$51.05M-$46.98M-$28.84M
2023-12-31$25.19M-$43.27M-$34.53M-$27.31M
2022-12-31$18.93M-$21.92M-$17.02M-$12.46M
2021-12-31$4.13M-$21.37M-$18.38M-$14.42M
2020-12-31$0-$16.76M-$16.91M-$16.25M
2019-12-31—-$19.78M-$19.78M-$15.79M
2018-12-31—-$16.58M-$16.65M-$11.78M
2017-12-31—-$8.08M-$8.07M-$7.26M
2016-12-31—-$5.73M-$5.74M-$4.79M

Company filings

events

  • Results

    Results
    Aug 58-K
  • Shareholder vote results

    Shareholder vote results
    Jun 118-K
  • Results

    Results
    May 68-K
  • Results

    Results
    Mar 168-K
  • Results

    Results
    11/4/20258-K

Insiders, politicians and funds

Insider trades, last 90 days

No insider buys or sales filed in the last 90 days.

Politician trades, last 90 days

No politician trades filed in the last 90 days.

Funds

None of the tracked funds held this at their last 13F.

News

Stories that named ZOMDF, and the market events around them.

Sign in to see this

Board

Recent signals

Signals open up here once a member has posted about ZOMDF.

Signals are informational.

Posts · 0

No posts yet.

Be the first to say something about ZOMDF.

nakagai

Signals on ZOMDF come from a rule, not a model.

Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.

Members post on the ZOMDF board

This page is not financial advice. Trade at your own judgment and risk. Read the terms that govern posting here.

Zomedica Corp. (ZOMDF): SEC filings, financials and insider trades · Nakagai